Literature DB >> 36043274

Changes in gastric morphology during long-term use of vonoprazan compared to proton pump inhibitors.

Satoshi Shinozaki1,2, Hiroyuki Osawa2, Yoshikazu Hayashi2, Hirotsugu Sakamoto2, Yoshimasa Miura2, Alan Kawarai Lefor3, Hironori Yamamoto2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36043274      PMCID： PMC9297186          DOI： 10.11622/smedj.2022076

Source DB:  PubMed          Journal:  Singapore Med J        ISSN： 0037-5675            Impact factor:   3.331


× No keyword cloud information.
  17 in total

1.  Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan.

Authors:  Michio Hongo; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2010-02-23       Impact factor: 7.527

2.  Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors:  P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal:  Gut       Date:  2016-10-05       Impact factor: 23.059

3.  Gastric mucosal cracked and cobblestone-like changes resulting from proton pump inhibitor use.

Authors:  Shuichi Miyamoto; Mototsugu Kato; Momoko Tsuda; Kana Matsuda; Tetsuhito Muranaka; Satoshi Abiko; Masayoshi Ono; Takeshi Mizushima; Saori Omori; Keiko Yamamoto; Katsuhiro Mabe; Shoko Ono; Takahiko Kudo; Yuichi Shimizu; Naoya Sakamoto
Journal:  Dig Endosc       Date:  2017-01-22       Impact factor: 7.559

4.  Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.

Authors:  M Jalving; J J Koornstra; J Wesseling; H M Boezen; S DE Jong; J H Kleibeuker
Journal:  Aliment Pharmacol Ther       Date:  2006-11-01       Impact factor: 8.171

5.  Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD: A Double-Blind Randomized Trial.

Authors:  Hólmfridur Helgadóttir; David C Metz; Sigrún H Lund; Sveinbjorn Gizurarson; Elin I Jacobsen; Gudrún A Asgeirsdóttir; Yrsa Yngadóttir; Einar S Björnsson
Journal:  J Clin Gastroenterol       Date:  2017-07       Impact factor: 3.062

6.  Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings.

Authors:  M Feldman; C T Richardson; J H Walsh
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

7.  Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype.

Authors:  T Kagami; S Sahara; H Ichikawa; T Uotani; M Yamade; M Sugimoto; Y Hamaya; M Iwaizumi; S Osawa; K Sugimoto; H Miyajima; T Furuta
Journal:  Aliment Pharmacol Ther       Date:  2016-03-18       Impact factor: 8.171

8.  Prevalence of Multiple White and Flat Elevated Lesions in Individuals Undergoing a Medical Checkup.

Authors:  Kyoichi Adachi; Tomoko Mishiro; Mayumi Okada; Yoshikazu Kinoshita
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

9.  Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach.

Authors:  Kosuke Takahari; Ken Haruma; Hiroshi Ohtani; Sho Kiyoto; Akifumi Watanabe; Tomoari Kamada; Noriaki Manabe; Yu Hatano
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271

10.  Multiple White and Flat Elevated Lesions Observed in the Stomach: A Prospective Study of Clinical Characteristics and Risk Factors.

Authors:  Kenichiro Majima; Yosuke Muraki; Takeshi Shimamoto
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.